The disclosure relates to thiosulfur containing compositions, in particular propyl-propane thiosulfonate (PTSO) and propyl-propane-thiosulfinate (PTS). Such compositions are useful for treating infection and reducing or degrading biofilms both in vivo and in vitro. In particular, such compositions are useful in the treatment of biofilm-related disorders, including but not limited to mastitis, digital dermatitis, and chronic wound infections.

The disclosure relates to thiosulfur containing compositions, in particular propyl-propane thiosulfonate (PTSO) and propyl-propane-thiosulfinate (PTS). Such compositions are useful for treating infection and reducing or degrading biofilms both in vivo and in vitro. In particular, such compositions are useful in the treatment of biofilm-related disorders, including but not limited to mastitis, digital dermatitis, and chronic wound infections.

The present disclosure is directed to a microbiostatic cleansing composition for use on skin and hard surfaces that reduces microbe resistance. The cleansing composition may be, for example, bacteriostatic or virostatic and includes a release agent that entangles the microbes without killing them allowing them to be removed from skin and hard surface in an inactive state.

The present disclosure is directed to a microbiostatic cleansing composition for use on skin and hard surfaces that reduces microbe resistance. The cleansing composition may be, for example, bacteriostatic or virostatic and includes a release agent that entangles the microbes without killing them allowing them to be removed from skin and hard surface in an inactive state.

The invention relates to compositions comprising at least one ABA antagonist for promoting germination/sprouting of plants or plant parts, and/or delaying fruit ripening and pigmentation; kits comprising such compositions; and methods of using such compositions to promote germination/sprouting of plants or plant parts, and/or to delay fruit ripening and pigmentation.

A method for reducing parasites in aquatic animals is provided. The method includes administering to the aquatic animal a compound comprising propyl propane thiosulfonate (PTSO) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 2 and also propyl propane thiosulfinate (PTS) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 1, so that a combination of PTS and PTSO is administered to the aquatic animal resulting in the reduction of a plurality of crustaceans infecting the aquatic animal in response to administering the combination of PTS and PTSO to the aquatic animal.

A method for reducing parasites in aquatic animals is provided. The method includes administering to the aquatic animal a compound comprising propyl propane thiosulfonate (PTSO) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 2 and also propyl propane thiosulfinate (PTS) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 1, so that a combination of PTS and PTSO is administered to the aquatic animal resulting in the reduction of a plurality of crustaceans infecting the aquatic animal in response to administering the combination of PTS and PTSO to the aquatic animal.

A method for reducing parasites in aquatic animals is provided. The method includes administering to the aquatic animal a compound comprising propyl propane thiosulfonate (PTSO) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 2 and also propyl propane thiosulfinate (PTS) having the formula R—SOa-S—R, where R represents n-propyl group (—CH.sub.2—CH.sub.2—CH.sub.3) and a is 1, so that a combination of PTS and PTSO is administered to the aquatic animal resulting in the reduction of a plurality of crustaceans infecting the aquatic animal in response to administering the combination of PTS and PTSO to the aquatic animal.

The invention relates to a disinfecting, skin-tolerable care agent for application to the skin or for the treatment thereof, comprising one or more water-soluble chlorine derivatives as a disinfecting active substance, wherein the chlorine derivative(s) is/are incorporated in a base creme or gel matrix and additionally contain(s) a substance mixture for odor-masking the chlorine component.

The invention relates to a disinfecting, skin-tolerable care agent for application to the skin or for the treatment thereof, comprising one or more water-soluble chlorine derivatives as a disinfecting active substance, wherein the chlorine derivative(s) is/are incorporated in a base creme or gel matrix and additionally contain(s) a substance mixture for odor-masking the chlorine component.